Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 4Phase NA 3Phase 1/2 2Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 7Stomach Neoplasms 3Lung Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Multiple Myeloma 2Carcinoma, Transitional Cell 2Carcinoma, Renal Cell 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 5Positron Emission Tomography Computed Tomography 4pembrolizumab 3Topotecan 2Surveys and Questionnaires 2Psilocybin 2Midazolam 2Methods 2Ketoconazole 2Ketamine 2temsirolimus 1posaconazole 1poly ICLC 1parathyroid hormone-related peptide (1-36) 1lavender oil 1jojoba wax 1ginger extract 1fluoromisonidazole 1fludarabine phosphate 1fludarabine 1fluciclovine F-18 1evolocumab 1etoposide phosphate 1beta-Glucans 1Whole-Body Irradiation 1Vincristine 1Varenicline 1Transplantation 1Transcranial Direct Current Stimulation 1Tetrahydrouridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neoplasms × Fluorodeoxyglucose F18 × Clear all
NCT06995976 2025-05-30

Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73

First Affiliated Hospital of Fujian Medical University

Phase EARLY_PHASE1 Recruiting
30 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡